RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $35 | -99.9% | 200,190 | +55.7% | 0.00% | – |
| Q3 2022 | $56,000 | -92.0% | 128,590 | -84.4% | 0.00% | -100.0% |
| Q2 2022 | $703,000 | +10.7% | 826,458 | +617.0% | 0.00% | 0.0% |
| Q1 2022 | $635,000 | -7.6% | 115,268 | +62.5% | 0.00% | 0.0% |
| Q4 2021 | $687,000 | +87.2% | 70,954 | +246.1% | 0.00% | – |
| Q3 2021 | $367,000 | -78.0% | 20,500 | -67.5% | 0.00% | -100.0% |
| Q1 2021 | $1,670,000 | +15.2% | 63,000 | -67.0% | 0.00% | 0.0% |
| Q4 2020 | $1,450,000 | +9.4% | 190,989 | -27.9% | 0.00% | +100.0% |
| Q3 2020 | $1,326,000 | +42.6% | 264,728 | +70.2% | 0.00% | 0.0% |
| Q2 2020 | $930,000 | – | 155,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |